These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11188741)

  • 1. [Antioxidant probucol is an efficient trap for lipid radicals in LDL in vitro and in vivo].
    Tikhaze AK; Lankin VZ; Konovalova GG; Shumaev KB; Kaminnyĭ AI; Kozachenko AI; Gurevich SM; Nagler LG; Zaĭtseva TM; Kukharchuk VV
    Biull Eksp Biol Med; 1999 Aug; 127(8):186-9. PubMed ID: 11188741
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of lipid peroxidation products and antioxidants on the formation of probucol radical in low density lipoproteins.
    Shumaev KB; Ruuge EK; Dmitrovsky AA; Bykhovsky VYa ; Kukharchuk VV
    Biochemistry (Mosc); 1997 Jun; 62(6):657-60. PubMed ID: 9284547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant effect of probucol on RO2*/O2(*-)-induced peroxidation of human low-density lipoproteins.
    Bonnefont-Rousselot D; Segaud C; Jore D; Delattre J; Gardès-Albert M
    Radiat Res; 1999 Mar; 151(3):343-53. PubMed ID: 10073673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza.
    Wu YJ; Hong CY; Lin SJ; Wu P; Shiao MS
    Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):481-6. PubMed ID: 9514418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms of anti-atherogenic action of probucol].
    Ohya T; Egusa G
    Nihon Rinsho; 1999 Dec; 57(12):2831-6. PubMed ID: 10638221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antioxidant probucol on cell-mediated LDL oxidation in vitro and in vivo.
    Bilenko MV; Khil'chenko AV; Konovalova GG; Lankin VZ
    Bull Exp Biol Med; 2003 Aug; 136(2):126-8. PubMed ID: 14631489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of phenol antioxidants on the development of alloxan diabetes in rats].
    Bobyreva LE
    Eksp Klin Farmakol; 1997; 60(3):51-3. PubMed ID: 9324400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is trimetazidine an antioxidant?].
    Tikhaze AK; Lankin VZ; Kolycheva SV; Konovalova GG; Shumaev KB; Kozachenko AI; Gurevich SM; Zharova EA; Smirnov LD
    Biull Eksp Biol Med; 1998 Nov; 126(11):551-4. PubMed ID: 9883367
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosis.
    Regnström J; Walldius G; Nilsson S; Elinder LS; Johansson J; Mölgaard J; Holme I; Olsson AG; Nilsson J
    Atherosclerosis; 1996 Sep; 125(2):217-29. PubMed ID: 8842353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of antioxidant action of vitamin E.
    Niki E; Noguchi N
    Acc Chem Res; 2004 Jan; 37(1):45-51. PubMed ID: 14730993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into controversies on the antioxidant potential of the olive oil antioxidant hydroxytyrosol.
    Rietjens SJ; Bast A; Haenen GR
    J Agric Food Chem; 2007 Sep; 55(18):7609-14. PubMed ID: 17683140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antioxidant probucol: effects on free radical lipid peroxidation, blood rheology and course of angina pectoris].
    Zakirova AN; Shamaev AG; Mirionkova NA
    Ter Arkh; 1998; 70(1):29-32. PubMed ID: 9532648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of 4,6-di-tert-butyl-2,3-dihydro-5-benzofuranols as a novel series of antiatherogenic antioxidants.
    Tamura K; Kato Y; Ishikawa A; Kato Y; Himori M; Yoshida M; Takashima Y; Suzuki T; Kawabe Y; Cynshi O; Kodama T; Niki E; Shimizu M
    J Med Chem; 2003 Jul; 46(14):3083-93. PubMed ID: 12825946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of antioxidants to prevent atherosclerosis development and its clinical manifestations.
    Pettersson KS; Ostlund-Lindqvist AM; Westerlund C
    EXS; 1996; 76():21-31. PubMed ID: 8805786
    [No Abstract]   [Full Text] [Related]  

  • 15. The resistance of low density lipoprotein to oxidation promoted by copper and its use as an index of antioxidant therapy.
    O'Leary VJ; Tilling L; Fleetwood G; Stone D; Darley-Usmar V
    Atherosclerosis; 1996 Jan; 119(2):169-79. PubMed ID: 8808494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin.
    Sakata N; Moh A; Takebayashi S
    Heart Vessels; 2002 Nov; 17(1):22-9. PubMed ID: 12434198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probucol does not inhibit myeloperoxidase-dependent low-density lipoprotein oxidation as a potent protective effect in atherosclerosis.
    Van Antwerpen P; Néve J; Moreau P; Boudjeltia KZ; Vanhaeverbeek M; Prévost M; Babar S; Legssyer I; Moguilevsky N; Ducobu J
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):350-1. PubMed ID: 17878766
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice.
    Hayek T; Attias J; Smith J; Breslow JL; Keidar S
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):540-4. PubMed ID: 9554802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal jammer. An academic experiment leads to a new class of drug for attacking heart disease.
    Stix G
    Sci Am; 2003 Jul; 289(1):29-31. PubMed ID: 12840943
    [No Abstract]   [Full Text] [Related]  

  • 20. Antioxidant properties of two novel 2-biphenylmorpholine compounds (EP2306 and EP2302) in vitro and in vivo.
    Tavridou A; Manolopoulos VG
    Eur J Pharmacol; 2004 Nov; 505(1-3):213-21. PubMed ID: 15556155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.